• March 29 - April 1, 2008
ACC 2008 Annual Scientific Session
Chicago, IL USA


• March 31, 2008
International Competitive Grants Awards Program for Young Investigators Awards Ceremony and Reception
Chicago, IL USA


• May 14 - 17, 2008
ASH 23rd Annual Scientific Meeting and Exposition
New Orleans, LA USA


• August 30 - Sept 03, 2008
ESC Congress 2008
Munich, Germany


• June 14 - 18, 2009
XV International Symposium On Atherosclerosis
Boston, MA USA


• Press Releases

• Foundation Fact Sheet

• Cardiovascular Fact Sheet
 
 
March 17, 2002

ATLANTA, GA - GLAXOSMITHKLINE RESEARCH & EDUCATION FOUNDATION AWARDS YOUNG INVESTIGATORS WITH $600,000 IN GRANTS FOR INNOVATIVE CARDIOVASCULAR RESEARCH

The GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease today announced the winners of its research grants program. The Competitive Grants Award Program for Young Investigators is a $600,000, 3-year grant program enabling young investigators and advanced cardiovascular disease fellows from all over the world to obtain funding for innovative research. The winners were honored at a reception held during the American College of Cardiology annual meeting in Atlanta, Georgia.*



AWARD RECIPIENTS TO CONDUCT CUTTING-EDGE RESEARCH

Dr. Gavin Blake, Fellow in Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, plans to study the links between systemic markers of inflammation and vulnerable plaque morphology using carotid MRI. The study, if successful, will represent a significant advance in our understanding of how plasma markers of inflammation can predict vascular risk.

Dr. Sana M. Al-Khatib, Associate in Medicine, Division of Cardiology, Duke University Medical Center, has dedicated her career to studying the diagnosis and treatment of arrhythmias using the integration of database studies. Dr. Al-Khatib is planning on using the funds from the grant to study the association of the two major epidemics of heart failure and atrial fibrillation, using the natural history to help define the best treatment for these major cardiovascular diseases.

Dr. Christopher Newton-Cheh, Fellow in Cardiology, Massachusetts General Hospital, has focused his work on the study of quality of care in heart failure research and genetic epidemiology. Dr. Newton-Cheh plans to focus on the genetic epidemiology of cardiovascular disease. This research will be conducted through the National Heart, Lung and Blood Institute's Program for Genomics Applications and Boston University School of Medicine.

Dr. Edwin Wu, Cardiology Fellow, Northwestern University, has co-authored a paper in the New England Journal of Medicine regarding prediction of recovery of regional and global left ventricular function after myocardial revascularization. Dr. Wu plans to use the grant money to study the effect of adenosine on improving the blood flow to the myocardium after primary angioplasty for myocardial infarction.

"We are very excited to be providing much needed resources to this outstanding group of young researchers," said Valentin Fuster, M.D., Ph.D., Director of the Cardiovascular Institute, at Mount Sinai School of Medicine in New York, New York and Chairman of the GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease. "There is not adequate research funding, especially for younger scientists. Our mission is to promote a new generation of clinician scientists by supporting the activities of promising researchers. Our hope is that by helping these promising young people in their research of today we are helping to devise the treatments of tomorrow."



FOUNDATION TO SPONSOR GENOMICS WORKSHOP

The Foundation was launched in November 2001. As part of its mission, the Foundation sponsors educational fora on cutting-edge topics. Its First Annual Symposium, Genomics and Cardiovascular Disease, will be held on June 14-15, 2002, in Philadelphia, PA. This state-of-the-art symposium will be led by distinguished leaders in the field who will address a wide range of topics including the basics of genomics and genetics, applications to cardiovascular research and evolving technologies in cardiology.



*This event is not part of the official American College of Cardiology (ACC) Annual Scientific Session as planned by the Annual Scientific Session Program Committee (AASPC).



The GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease receives support through a grant from GlaxoSmithKline.


Other Press Releases:

• January 28, 2008

• January 22, 2007

• February 09, 2006

• March 15, 2005

• March 3, 2004

• March 27, 2003

• March 17, 2002

• November 10, 2001




Press Kit entries feature recent and past press releases and other background information on the GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease.

The press releases posted on this site are intended for journalists.

Legal Notices  |  Privacy Statement  |  Contact Us

©2001-2008 GlaxoSmithKline. All Rights Reserved.